Sunday 4 June 2017

Candidate(s) for global eradication by WHO | PGI Nov 2017 Preparations MCQ

NIME Next Batch PGI Quest in Delhi from 10 August to 20 August


Drug of choice for Methicillin resistant staphylococcus aureus is (MRSA) 


A. Amoxicillin-Clavulanate 
B. Vancomycin 
C. Flucloxacillin 
D. Clindamycin 
E. Erythromycin



Ans. B. Vancomycin :
• Vancomycin is the drug of choice of MRSA infections.
• Although sensitive strains may be amenable to therapy with clindamycin or trimethoprim-sulfamethoxazole— but many strains are resistant to them.
• New antibiotic quinopristin/dalfopristin and linezolid offer promise for treatment of MRSA, further studies are needed for their recommendation.
• Unfortunately, increased use of vancomycin has resulted in emergence of both vancomycin-intermediate S. Aureus (VISA), and Vancomycin resistant enterococci (VRE).
• Optimal therapy for VISA is unknown.

Note :Teicoplanin can also be used in MRSA infections.